首页> 外国专利> Process for the preparation of DNA primers and probes for minimally invasive prenatal PCR diagnosis of Trisomy 21 chromosome in the fetus ON blood of pregnant women, kits comprising primers and probes derived in accordance with this method, and minimally invasive diagnostic method that uses said primers AND PROBES

Process for the preparation of DNA primers and probes for minimally invasive prenatal PCR diagnosis of Trisomy 21 chromosome in the fetus ON blood of pregnant women, kits comprising primers and probes derived in accordance with this method, and minimally invasive diagnostic method that uses said primers AND PROBES

机译:用于制备孕妇胎儿血液中的21三体染色体的微创产前PCR诊断DNA引物和探针的方法,包含引物和根据该方法衍生的探针的试剂盒以及使用所述引物的微创诊断方法问题

摘要

1. A method of obtaining DNA primers and probes for minimally invasive prenatal PCR diagnosis of trisomy of the 21st chromosome in the fetus by the blood of a pregnant woman, which uses: (a) site-specific restriction endonuclease (s), sensitive ( -th) for methylation, (b) a sample of human hypermethylated or fetal DNA, (c) a sample of hypomethylated or adult human DNA, characterized in that it comprises the following steps: (1) select a site for differential methylation of fetal DNA of the 21st chromosome and DNA of the 21st chromosome adult s sensitive to said endonuclease (s), (2) synthesize the forward and reverse primers corresponding to an amplicon from 60 to 300 pairs of nucleotides in length containing the differential methylation site (s) of the 21st chromosome, as well as a probe corresponding to this amplicon, (3) carry out the polymerase chain reaction of a mixture of samples (b) and (c) after their treatment with restriction endonuclease (a), at least at three different concentration ratios of these samples, (4) pairs of primers and probes are selected to ensure efficiency reaction and PCR above 90% and linearity when changing the relative concentration of samples (b) and (c) above 0.9.2. A kit for minimally invasive prenatal PCR diagnosis of trisomy of the 21st chromosome in the fetus by the blood of a pregnant woman, containing at least one pair consisting of direct and reverse primers obtained in accordance with the method of claim 1, and at least , one probe corresponding to them. 3. A kit according to claim 2, characterized in that the amplicon size is an integer in the range from 60 to 300 nucleotide pairs, preferably an integer in the range
机译:1.一种获得DNA引物和探针的方法,该方法可通过孕妇的血液进行微创的产前PCR诊断胎儿21染色体三体性诊断,该方法使用:(a)敏感的位点特异性限制性内切核酸酶。 -th)用于甲基化,(b)人高甲基化或胎儿DNA的样品,(c)低甲基化或成人人DNA的样品,其特征在于它包括以下步骤:(1)选择胎儿的差异甲基化位点对所述核酸内切酶敏感的21号染色体的DNA和21号染色体的成年人的DNA,(2)合成正向和反向引物,它们对应于长度为60至300对核苷酸的扩增子,其中包含差异甲基化位点)和对应于该扩增子的探针,(3)在用限制性核酸内切酶(a)处理后,样品(b)和(c)的混合物进行聚合酶链反应,至少在三种不同的骗局选择这些样品的浓度比,(4)对引物和探针,以确保当改变样品(b)和(c)的相对浓度高于0.9.2时,反应和PCR效率均高于90%,并且线性良好。 16.一种用于通过孕妇的血液对胎儿的第21染色体三体进行微创产前PCR诊断的试剂盒,其包含至少一对由根据权利要求1的方法获得的正向和反向引物组成,并且至少,与它们相对应的一个探针。 3.根据权利要求2所述的试剂盒,其特征在于,所述扩增子的大小是60至300个核苷酸对范围内的整数,优选范围内的整数。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号